Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.644
+0.041 (6.77%)
Mar 9, 2026, 2:04 PM EDT - Market open
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $26.29 million as of March 9, 2026. Its market cap has decreased by -38.06% in one year.
Market Cap
26.29M
Enterprise Value
-37.18M
1-Year Change
-38.06%
Ranking
Category
Stock Price
$0.64
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $26.29M, a decrease of -95.46%. That is a compound annual growth rate of -47.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 24.62M | -13.87% |
| Dec 31, 2025 | 28.59M | -41.18% |
| Dec 31, 2024 | 48.60M | -65.85% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AEON Biopharma | 26.82M |
| Passage Bio | 26.70M |
| Evaxion | 26.52M |
| Exicure | 26.45M |
| Hyperion DeFi | 26.12M |
| Senti Biosciences | 25.37M |
| Boundless Bio | 25.29M |
| Vistagen Therapeutics | 24.08M |